Nonetheless, this study establishes a solid foundation for the rational design of peptide-based inhibitors targeting Aβ oligomers, and underscores the therapeutic potential of APR-derived peptide analogs of Cathepsin B in combating Alzheimer’s disease. The gene discussed is CTSB; the disease is early-onset autosomal dominant Alzheimer disease.